Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ACU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -0.367M
March 31, 2026 -0.097M
December 31, 2025 0.0005M
September 30, 2025 -0.096M
June 30, 2025 -0.602M
March 31, 2025 0.00
December 31, 2024 -0.2382M
September 30, 2024 -0.411M
June 30, 2024 -0.649M
March 31, 2024 -0.323M
December 31, 2023 -0.9265M
September 30, 2023 -0.237M
June 30, 2023 -0.228M
March 31, 2023 -0.061M
December 31, 2022 -0.0067M
September 30, 2022 -0.068M
June 30, 2022 -0.01M
March 31, 2022 0.00
December 31, 2021 1.450M
September 30, 2021 -0.368M
June 30, 2021 -2.516M
March 31, 2021 -0.182M
December 31, 2020 0.0002M
September 30, 2020 -0.059M
June 30, 2020 0.073M
Date Value
March 31, 2020 0.214M
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.3651M
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 -0.0002M
September 30, 2017 -0.021M
June 30, 2017 -0.442M
March 31, 2017 -0.186M
December 31, 2016 -0.0044M
September 30, 2016 0.00
June 30, 2016 0.022M
March 31, 2016 0.495M
December 31, 2015 0.4079M
September 30, 2015 -0.302M
June 30, 2015 -0.354M
March 31, 2015 -0.321M
December 31, 2014 -0.2487M
September 30, 2014 -0.717M
June 30, 2014 -0.173M
March 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Cencora, Inc. 1.000B
Abbott Laboratories 1.042B
Align Technology, Inc. 66.93M
AngioDynamics, Inc. 0.011M
Accuray, Inc. -0.149M